Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

NCT07363369 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

BIOLOGICAL: FAP mRNA vaccine (dose 1) + immune checkpoint inhibitors
BIOLOGICAL: FAP mRNA vaccine (dose 2) + immune checkpoint inhibitors
BIOLOGICAL: FAP mRNA vaccine (dose 3) + immune checkpoint inhibitors
BIOLOGICAL: FAP mRNA vaccine (dose 4) + immune checkpoint inhibitors

Sponsor

West China Hospital